FDA Inspection 859009 — Xytex Cryo International

Xytex Cryo International — FEI 3012211124

The FDA completed an inspection of Xytex Cryo International on Dec 16, 2013 in New Brunswick, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 16, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New Brunswick, NJ (United States)

Citations

IDCFRDescription
1225421 CFR 1271.60(b)Identified as quarantined, distinguishable
1249321 CFR 1271.90(c)Eligibility not required--warning labels